Thailand Clinical Laboratory Market Outlook to 2026F

Thailand Clinical Laboratory Market Outlook to 2026F

The report provides a comprehensive analysis of the potential of the Clinical Laboratory Market in Thailand. The report covers an overview and genesis of the industry, market size in terms of revenue generated.

The market is segmented by independent laboratory, by payer, by customers, by type of tests, by type of routine tests, by type of esoteric tests, by region, by type of laboratory in private hospitals; growth enablers and drivers, challenges and bottlenecks, trends; regulatory framework; industry analysis, competitive landscape including competition scenario and market shares of major players. The report concludes with future market projections of each segmentation and analyst recommendations.

Market Overview:

According to Ken Research estimates, the Thailand Clinical Laboratory Market – which grew at a CAGR of 9.0% in the period of 2016-2021 – is expected to grow at a CAGR of 9.5% in the forecasted period of 2022F-2026F, owing to the increasing healthcare spending by aging population, expanding healthcare spending by the Government, growth in non-communicable disease and chronic diseases and increasing public awareness.

The market is led by N Health; having the major share of the Clinical Laboratory Market in Thailand. Other players include Pathlab, Thonburi Clinical Labs, Bangkok Medical Labs, Medical Line Lab, Innotech Laboratories and others.

Around 60.0% of medical decisions regarding early disease diagnosis, patient prognosis and treatment selection are based on laboratory diagnostic results.

Key Trends by Market Segment:

By Payer: Private health insurance makes up the majority of the revenue sources for laboratories. Private health insurance is an option for expats in Thailand who want a larger variety of coverage or are ineligible for public health insurance. One can receive treatment in any public or private hospital in Thailand if they purchase a private insurance plan.

By Type of Routine Test: CBC is the most common routine test performed. The prevalence of numerous infectious diseases is on the rise, which presents a favourable chance for the industry to expand. The need for patient monitoring via blood testing services is growing along with medical tourism. The region's blood-testing sector has benefited from this.

Competitive Landscape

Future Outlook

The Thailand Clinical Laboratory Market is projected to show a growth of CAGR 9.5% in the forecasted period of 2022F-2026F, owing to the increasing healthcare spending by aging population, expanding healthcare spending by the Government, growth in non-communicable disease and chronic diseases, increasing focus on preventive medicine, rising disposable income resulted in increasing demand for health check-ups, preference for evidence-based treatment and increasing public awareness.

Please Note:It will take 5-7 business days to complete the report upon order confirmation.